In the SCLC and NSCLC specimens, a subpopulation of tumorigenic cells expressing CD133 were identified exhibiting tumor-forming abilities and could generate lung tumor xenografts identical to the original tumor [42]. This evidence concerns the gene PROM1 and non-small cell lung carcinoma.